|
PPP1CB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.57580000000369E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.233200E-04 |
| Normal-vs-Stage2 |
8.118200E-03 |
| Normal-vs-Stage3 |
2.17419999999358E-05 |
| Normal-vs-Stage4 |
2.13429999995629E-06 |
| Stage1-vs-Stage2 |
9.081800E-01 |
| Stage1-vs-Stage3 |
8.592100E-02 |
| Stage1-vs-Stage4 |
6.797000E-03 |
| Stage2-vs-Stage3 |
3.348600E-01 |
| Stage2-vs-Stage4 |
1.511580E-01 |
| Stage3-vs-Stage4 |
5.560400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.383840E-04 |
| Normal-vs-AfricanAmerican |
5.76210000047261E-07 |
| Normal-vs-Asian |
2.540600E-01 |
| Caucasian-vs-AfricanAmerican |
7.224300E-03 |
| Caucasian-vs-Asian |
7.578200E-01 |
| AfricanAmerican-vs-Asian |
1.397970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.420470E-04 |
| Normal-vs-Female |
5.635100000001E-05 |
| Male-vs-Female |
4.895000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.448200E-04 |
| Normal-vs-Age(41-60Yrs) |
7.023900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.51309999999661E-05 |
| Normal-vs-Age(81-100Yrs) |
5.85300000000011E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.782400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.913200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.567200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.031390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.940400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.159600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.705720E-02 |
| Normal-vs-Grade 2 |
2.561600E-03 |
| Normal-vs-Grade 3 |
1.50581999999178E-05 |
| Normal-vs-Grade 4 |
1.6712999995061E-07 |
| Grade 1-vs-Grade 2 |
8.060600E-01 |
| Grade 1-vs-Grade 3 |
2.298800E-01 |
| Grade 1-vs-Grade 4 |
4.504200E-02 |
| Grade 2-vs-Grade 3 |
3.864500E-03 |
| Grade 2-vs-Grade 4 |
7.79700000000938E-05 |
| Grade 3-vs-Grade 4 |
3.392500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.202500E-03 |
| Normal-vs-ccB subtype |
1.974860E-04 |
| ccA subtype-vs-ccB subtype |
5.108300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.553680E-04 |
| Normal-vs-N1 |
3.841000E-03 |
| N0-vs-N1 |
6.840600E-01 |
|
|
